Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells.

导出 OA

翻译打印收藏纠错

作者： Nada,Amri ^[1] ; Rémi,Bégin ^[2] ; Nolwenn,Tessier ^[1] ; Laurent,Vachon ^[2] ; Louis,Villeneuve ^[1] ; Philippe,Bégin ^[2] ; Renée,Bazin ^[1] ; Lionel,Loubaki ^[2] ; Catherine,Martel ^[2]

作者单位： Faculty of Medicine, Université de Montréal, Pavillon Roger-Gaudry, 2900 Edouard Montpetit Blvd, Montreal, QC H3T 1J4, Canada. ^[1] Montreal Heart Institute, 5000 Belanger Street, Montreal, QC H1T 1C8, Canada. ^[2] Department of Pediatrics, CHU Sainte-Justine, 3175 Chem. de la Côte-Sainte-Catherine, Montreal, QC H3T 1C5, Canada. ^[3] Department of Medicine, Centre Hospitalier de l'Université de Montréal, 900 Rue Saint-Denis, Montreal, QC H2X 0A9, Canada. ^[4] Medical Affairs and Innovation, Héma-Québec, 1070 Avenue des Sciences-de-la-Vie, Québec, QC G1V 5C3, Canada. ^[5]

关键词 COVID-19 convalescent plasma therapy endothelium extracellular vesicles lymphatics

DOI 10.3390/ph15030365

PMID 35337162

发布时间 2022-03-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交